Diabetes screening study finds no reduction in mortality rates

October 3, 2012

The randomised trial, which is the first ever study evaluating the effect of type 2 diabetes screening programmes on overall mortality rates in a population, assessed the number of deaths over ten years in a group of more than 20 000 patients across 32 general practices in Eastern England. The patients were all aged between 40 and 69 years, and were assessed as being at high risk of diabetes.

Researchers allocated the practices participating in the trial to one of three groups: a group where one round of screening was followed up by routine care for patients diagnosed with diabetes; a group where one round of screening was followed up by intensive management of patients diagnosed with diabetes; and a control group where no screening took place. They then tracked mortality rates in the patients studied over a period of 9.6 years on average (median).

The authors of the study found that overall mortality was not reduced in the groups where screening took place. They also found no significant difference between the screened and non-screened groups in the number of deaths specifically attributable to diabetes, cardiovascular illness, cancer, or other causes of death.

According to Dr Simon Griffin, of the MRC Epidemiology Unit at Addenbrooke's Hospital in Cambridge, UK, "The high proportion of undiagnosed cases of diabetes, the substantial number of patients with complications at clinical diagnosis, and the long latent phase of the disease are strong arguments for screening. However, in the large UK sample that we studied, screening for type 2 diabetes in patients at increased risk of the disease was not associated with any reduction in mortality within ten years."*

"It seems that the benefits of screening might be smaller than expected and restricted to individuals with detectable disease. However, benefits to the population could be increased by including the detection and management of cardiovascular risk factors alongside the assessment of diabetes risk, performing repeated rounds of screening, and improving strategies to maximise the uptake of screening."*

The authors point out that despite the large sample size, their study has a number of limitations, including the fact that the study took place in an area of the UK of above-average affluence, and they warn that particular caution should be exercised in extrapolating the results to more socially disadvantaged communities, where the disease risk may be higher and attendance for screening is likely to be lower.

In a linked Comment, Michael Engelgau of the Centers for Disease Control and Prevention in Atlanta, Georgia, USA, writes, "Diabetes screening and diagnosis can be done with relative ease, which further escalates popular support for wide-scale screening. However, these compelling arguments overlook the screening costs, potential harms, and lack of clear evidence that screening improves health outcomes compared with current routine clinical diagnosis."

"This study increases the doubt about the value of wide-scale screening for undiagnosed diabetes alone, and deserves credit for tackling the screening quandary head-on. Nevertheless, for any one study to address the diverse factors that affect screening policies—ranging from the magnitude of population burden of disease to the capacity and effectiveness of prevention approaches—is a tall order. Screening recommendations are therefore likely to be country specific and context-specific for the foreseeable future."

Explore further: Study finds mammography screening reduces breast cancer mortality

More information: Study online: www.thelancet.com/journals/lan … (12)61422-6/abstract

Related Stories

Study finds mammography screening reduces breast cancer mortality

June 28, 2011
Breast cancer screening with mammography results in a significant reduction in breast cancer mortality, according to long-term follow-up results of a large-scale Swedish trial. The results are published online in the journal ...

PSA screening to detect prostate cancer can be beneficial to younger and at-risk men: study

May 7, 2012
Screening younger men and men at risk of prostate cancer can be beneficial in reducing metastatic cancer and deaths and should not be abandoned, states an article published in CMAJ (Canadian Medical Association Journal).

Study reveals optimal interval for stomach cancer screening

July 16, 2012
A new study has determined how often people should get screened for gastric or stomach cancer in high-risk regions of the world. Published early online in Cancer, a peer-reviewed journal of the American Cancer Society, the ...

Diabetic retinopathy research could reduce screening costs

May 7, 2012
Research carried out at the Peninsula College of Medicine and Dentistry (PCMD), University of Exeter, has concluded that it would be a safe and cost-effective strategy to screen people with type 2 diabetes who have not yet ...

Recommended for you

Screen time linked to diabetes

July 28, 2017
Daily screen time of three or more hours is linked to several risk factors associated with the development of diabetes in children, according to a study by St George's, University of London.

People who drink 3 to 4 times per week less likely to develop diabetes than those who never drink: study

July 27, 2017
Frequent alcohol consumption is associated with a reduced risk of diabetes in both men and women, according to a new study published in Diabetologia (the journal of the European Association for the Study of Diabetes), with ...

Diabetes can be tracked with our Google searches

July 26, 2017
The emergence of Type 2 Diabetes could be more effectively monitored using our Google searches—helping public health officials keep track of the disease and halt its spread—according to research by the University of Warwick.

Scientists discover a new way to treat type 2 diabetes

July 21, 2017
Medication currently being used to treat obesity is also proving to have significant health benefits for patients with type 2 diabetes. A new study published today in Molecular Metabolism explains how this therapeutic benefit ...

Alzheimer's drug cuts hallmark inflammation related to metabolic syndrome by 25 percent

July 20, 2017
An existing Alzheimer's medication slashes inflammation and insulin resistance in patients with metabolic syndrome, a potential therapeutic intervention for a highly dangerous condition affecting 30 percent of adults in the ...

Diabetes or its precursor affects 100 million Americans

July 19, 2017
Almost one-third of the US population—100 million people—either has diabetes or its precursor condition, known as pre-diabetes, said a government report Tuesday.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.